As World AIDS Day is celebrated across the world on 1 December 2006, UNAIDS partners including Cosponsor organizations, UNAIDS Special Representatives, civil society and faith-based organizations release commemorative messages.
UN Secretary-General Kofi Annan was joined by UNAIDS Executive Director Dr Peter Piot and leaders of different faiths to commemorate World AIDS Day at St. Bartholomew?s Episcopal Church in New York.
Pfizer announced today that it plans to establish a multi-national Expanded Access Program (EAP) to make the investigational CCR5 antagonist maraviroc, currently in ongoing phase 3 clinical trials, available to HIV/AIDS patients with CCR5-tropic HIV-1 who have limited or no approved treatment options due to resistance or intolerance.
The South African government is expected to announce a newly-revised AIDS-combating strategy this week with intensified prevention and treatment measures, a long-waited boost to the country’s arduous fight against the world’s most serious AIDS epidemic.
The Gauteng health department has initiated a door-to-door campaign, aimed at educating over one million residents about HIV and AIDS prevention and care.
Findings from one of the largest HIV/AIDS therapy studies conducted to date show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause.
Taking HIV patients off medications during periods when the disease appears to be under control is a risky – and sometimes fatal – treatment strategy, according to a large international study published in the New England Journal of Medicine.
Thailand Health Ministry has issued its first compulsory licence to make a cheaper version of Efavirenz, a life-saving medicine sold by a major international drug company, Merck & Co Inc, which holds the patent on the drug also known as Stocrin.
Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. In the study, the investigators used two predetermined levels of CD4+ T cells, the primary immune cell targeted by HIV, to guide them in respectively suspending or restarting the study participants on antiretroviral therapy.
More people are voluntarily getting tested for HIV, worldwide. Today, the department of health, South Africa revealed that more South Africans are voluntarily getting counselled and tested for HIV with figures rising annually.